This study focuses on individuals who were previously diagnosed with COVID-19 infection. The study will examine how COVID-19 affects endocrine hormone function and whether changes in hormone levels impact symptoms such as fatigue, weakness, low energy, brain fogginess, and body pain. Additionally, researchers aim to determine how hormone levels, such as thyroid, cortisol, testosterone, estrogen, and growth hormone, change after COVID-19 infection. There is evidence that COVID-19 can lead to pituitary hormone deficiency and inflammation. The pituitary gland releases a number of hormones that act on nearly every part of the body. Researchers hope that this study will lead to timely diagnosis and management of possible pituitary dysfunction in people who have been infected with COVID-19. Participants will be asked to provide blood samples, as well as complete a brief online questionnaire about quality of life related to pituitary hormone deficiency.
Not Available
What is the full name of this clinical trial?
Assess Pituitary Function in COVID-19 Patients and Correlate Results with Clinical Symptoms Fatigue